196 related articles for article (PubMed ID: 37956856)
1. Targeting the αVβ3/NgR2 pathway in neuroendocrine prostate cancer.
Testa A; Quaglia F; Naranjo NM; Verrillo CE; Shields CD; Lin S; Pickles MW; Hamza DF; Von Schalscha T; Cheresh DA; Leiby B; Liu Q; Ding J; Kelly WK; Hooper DC; Corey E; Plow EF; Altieri DC; Languino LR
Matrix Biol; 2023 Dec; 124():49-62. PubMed ID: 37956856
[TBL] [Abstract][Full Text] [Related]
2. The NOGO receptor NgR2, a novel αVβ3 integrin effector, induces neuroendocrine differentiation in prostate cancer.
Quaglia F; Krishn SR; Sossey-Alaoui K; Rana PS; Pluskota E; Park PH; Shields CD; Lin S; McCue P; Kossenkov AV; Wang Y; Goodrich DW; Ku SY; Beltran H; Kelly WK; Corey E; Klose M; Bandtlow C; Liu Q; Altieri DC; Plow EF; Languino LR
Sci Rep; 2022 Nov; 12(1):18879. PubMed ID: 36344556
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of αVβ3 and αVβ6 integrins in prostate cancer progression.
Quaglia F; Krishn SR; Wang Y; Goodrich DW; McCue P; Kossenkov AV; Mandigo AC; Knudsen KE; Weinreb PH; Corey E; Kelly WK; Languino LR
PLoS One; 2021; 16(1):e0244985. PubMed ID: 33481853
[TBL] [Abstract][Full Text] [Related]
4. Prostate cancer sheds the αvβ3 integrin in vivo through exosomes.
Krishn SR; Singh A; Bowler N; Duffy AN; Friedman A; Fedele C; Kurtoglu S; Tripathi SK; Wang K; Hawkins A; Sayeed A; Goswami CP; Thakur ML; Iozzo RV; Peiper SC; Kelly WK; Languino LR
Matrix Biol; 2019 Apr; 77():41-57. PubMed ID: 30098419
[TBL] [Abstract][Full Text] [Related]
5. Insulin-like growth factor-I promotes migration in human androgen-independent prostate cancer cells via the alphavbeta3 integrin and PI3-K/Akt signaling.
Montagnani Marelli M; Moretti RM; Procacci P; Motta M; Limonta P
Int J Oncol; 2006 Mar; 28(3):723-30. PubMed ID: 16465378
[TBL] [Abstract][Full Text] [Related]
6. BKCa promotes growth and metastasis of prostate cancer through facilitating the coupling between αvβ3 integrin and FAK.
Du C; Zheng Z; Li D; Chen L; Li N; Yi X; Yang Y; Guo F; Liu W; Xie X; Xie M
Oncotarget; 2016 Jun; 7(26):40174-40188. PubMed ID: 27233075
[TBL] [Abstract][Full Text] [Related]
7. Role of α5β1 and αvβ3 integrins in relation to adhesion and spreading dynamics of prostate cancer cells interacting with fibronectin under in vitro conditions.
Stachurska A; Elbanowski J; Kowalczyńska HM
Cell Biol Int; 2012 Oct; 36(10):883-92. PubMed ID: 22686483
[TBL] [Abstract][Full Text] [Related]
8. Exosome-mediated Transfer of αvβ3 Integrin from Tumorigenic to Nontumorigenic Cells Promotes a Migratory Phenotype.
Singh A; Fedele C; Lu H; Nevalainen MT; Keen JH; Languino LR
Mol Cancer Res; 2016 Nov; 14(11):1136-1146. PubMed ID: 27439335
[TBL] [Abstract][Full Text] [Related]
9. Integrin αvβ3 and CD44 pathways in metastatic prostate cancer cells support osteoclastogenesis via a Runx2/Smad 5/receptor activator of NF-κB ligand signaling axis.
Gupta A; Cao W; Chellaiah MA
Mol Cancer; 2012 Sep; 11():66. PubMed ID: 22966907
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of αvβ3 integrin impairs adhesion and uptake of tumor-derived small extracellular vesicles.
Altei WF; Pachane BC; Dos Santos PK; Ribeiro LNM; Sung BH; Weaver AM; Selistre-de-Araújo HS
Cell Commun Signal; 2020 Sep; 18(1):158. PubMed ID: 32988382
[TBL] [Abstract][Full Text] [Related]
11. Small extracellular vesicle-mediated
Krishn SR; Garcia V; Naranjo NM; Quaglia F; Shields CD; Harris MA; Kossenkov AV; Liu Q; Corey E; Altieri DC; Languino LR
Cancer Biol Ther; 2022 Dec; 23(1):173-185. PubMed ID: 35188070
[TBL] [Abstract][Full Text] [Related]
12. Single cell tracking assay reveals an opposite effect of selective small non-peptidic α5β1 or αvβ3/β5 integrin antagonists in U87MG glioma cells.
Ray AM; Schaffner F; Janouskova H; Noulet F; Rognan D; Lelong-Rebel I; Choulier L; Blandin AF; Lehmann M; Martin S; Kapp T; Neubauer S; Rechenmacher F; Kessler H; Dontenwill M
Biochim Biophys Acta; 2014 Sep; 1840(9):2978-87. PubMed ID: 24810979
[TBL] [Abstract][Full Text] [Related]
13. Engineered fibronectin type III domain with a RGDWXE sequence binds with enhanced affinity and specificity to human alphavbeta3 integrin.
Richards J; Miller M; Abend J; Koide A; Koide S; Dewhurst S
J Mol Biol; 2003 Mar; 326(5):1475-88. PubMed ID: 12595259
[TBL] [Abstract][Full Text] [Related]
14. CCL2 increases αvβ3 integrin expression and subsequently promotes prostate cancer migration.
Lin TH; Liu HH; Tsai TH; Chen CC; Hsieh TF; Lee SS; Lee YJ; Chen WC; Tang CH
Biochim Biophys Acta; 2013 Oct; 1830(10):4917-27. PubMed ID: 23845726
[TBL] [Abstract][Full Text] [Related]
15. α
Wang T; Huang J; Vue M; Alavian MR; Goel HL; Altieri DC; Languino LR; FitzGerald TJ
Mol Cancer Res; 2019 Feb; 17(2):398-408. PubMed ID: 30266752
[TBL] [Abstract][Full Text] [Related]
16. Prostate cancer specific integrin alphavbeta3 modulates bone metastatic growth and tissue remodeling.
McCabe NP; De S; Vasanji A; Brainard J; Byzova TV
Oncogene; 2007 Sep; 26(42):6238-43. PubMed ID: 17369840
[TBL] [Abstract][Full Text] [Related]
17. Prostate cancer targeting motifs: expression of αν β3, neurotensin receptor 1, prostate specific membrane antigen, and prostate stem cell antigen in human prostate cancer cell lines and xenografts.
Taylor RM; Severns V; Brown DC; Bisoffi M; Sillerud LO
Prostate; 2012 Apr; 72(5):523-32. PubMed ID: 21748756
[TBL] [Abstract][Full Text] [Related]
18. Leptin increases motility and integrin up-regulation in human prostate cancer cells.
Huang CY; Yu HS; Lai TY; Yeh YL; Su CC; Hsu HH; Tsai FJ; Tsai CH; Wu HC; Tang CH
J Cell Physiol; 2011 May; 226(5):1274-82. PubMed ID: 20945385
[TBL] [Abstract][Full Text] [Related]
19. Integrin expression and glycosylation patterns regulate cell-matrix adhesion and alter with breast cancer progression.
Singh C; Shyanti RK; Singh V; Kale RK; Mishra JPN; Singh RP
Biochem Biophys Res Commun; 2018 May; 499(2):374-380. PubMed ID: 29577899
[TBL] [Abstract][Full Text] [Related]
20. CXCR6-CXCL16 axis promotes prostate cancer by mediating cytoskeleton rearrangement via Ezrin activation and αvβ3 integrin clustering.
Singh R; Kapur N; Mir H; Singh N; Lillard JW; Singh S
Oncotarget; 2016 Feb; 7(6):7343-53. PubMed ID: 26799186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
